Lona Mody1, Sarah L Krein2, Sanjay Saint2, Lillian C Min1, Ana Montoya3, Bonnie Lansing3, Sara E McNamara3, Kathleen Symons4, Jay Fisch5, Evonne Koo3, Ruth Anne Rye6, Andrzej Galecki7, Mohammed U Kabeto3, James T Fitzgerald8, Russell N Olmsted9, Carol A Kauffman10, Suzanne F Bradley10. 1. Division of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor2Geriatric Research, Education and Clinical Center, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan. 2. Center for Clinical Management Research, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan4Division of General Medicine, University of Michigan Health System, Ann Arbor. 3. Division of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor. 4. Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan. 5. Division of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor6currently with the Rosenstiel School of Marine and Atmospheric Science, University of Miami, Miami, Florida. 6. currently a long-term care infection prevention and control consultant in Hemlock, Michigan. 7. Division of Geriatric and Palliative Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor8Department of Biostatistics, University of Michigan Medical School, Ann Arbor. 8. Geriatric Research, Education and Clinical Center, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan9Department of Medical Education, University of Michigan Medical School, Ann Arbor. 9. Department of Infection Prevention and Control, St Joseph Mercy Health System, Ann Arbor, Michigan. 10. Infectious Diseases, Veterans Affairs Ann Arbor Healthcare System, Ann Arbor, Michigan11Division of Infectious Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor.
Abstract
IMPORTANCE: Indwelling devices (eg, urinary catheters and feeding tubes) are often used in nursing homes (NHs). Inadequate care of residents with these devices contributes to high rates of multidrug-resistant organisms (MDROs) and device-related infections in NHs. OBJECTIVE: To test whether a multimodal targeted infection program (TIP) reduces the prevalence of MDROs and incident device-related infections. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial at 12 community-based NHs from May 2010 to April 2013. Participants were high-risk NH residents with urinary catheters, feeding tubes, or both. INTERVENTIONS: Multimodal, including preemptive barrier precautions, active surveillance for MDROs and infections, and NH staff education. MAIN OUTCOMES AND MEASURES: The primary outcome was the prevalence density rate of MDROs, defined as the total number of MDROs isolated per visit averaged over the duration of a resident's participation. Secondary outcomes included new MDRO acquisitions and new clinically defined device-associated infections. Data were analyzed using a mixed-effects multilevel Poisson regression model (primary outcome) and a Cox proportional hazards model (secondary outcome), adjusting for facility-level clustering and resident-level variables. RESULTS: In total, 418 NH residents with indwelling devices were enrolled, with 34,174 device-days and 6557 anatomic sites sampled. Intervention NHs had a decrease in the overall MDRO prevalence density (rate ratio, 0.77; 95% CI, 0.62-0.94). The rate of new methicillin-resistant Staphylococcus aureus acquisitions was lower in the intervention group than in the control group (rate ratio, 0.78; 95% CI, 0.64-0.96). Hazard ratios for the first and all (including recurrent) clinically defined catheter-associated urinary tract infections were 0.54 (95% CI, 0.30-0.97) and 0.69 (95% CI, 0.49-0.99), respectively, in the intervention group and the control group. There were no reductions in new vancomycin-resistant enterococci or resistant gram-negative bacilli acquisitions or in new feeding tube-associated pneumonias or skin and soft-tissue infections. CONCLUSIONS AND RELEVANCE: Our multimodal TIP intervention reduced the overall MDRO prevalence density, new methicillin-resistant S aureus acquisitions, and clinically defined catheter-associated urinary tract infection rates in high-risk NH residents with indwelling devices. Further studies are needed to evaluate the cost-effectiveness of this approach as well as its effects on the reduction of MDRO transmission to other residents, on the environment, and on referring hospitals. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01062841.
RCT Entities:
IMPORTANCE: Indwelling devices (eg, urinary catheters and feeding tubes) are often used in nursing homes (NHs). Inadequate care of residents with these devices contributes to high rates of multidrug-resistant organisms (MDROs) and device-related infections in NHs. OBJECTIVE: To test whether a multimodal targeted infection program (TIP) reduces the prevalence of MDROs and incident device-related infections. DESIGN, SETTING, AND PARTICIPANTS: Randomized clinical trial at 12 community-based NHs from May 2010 to April 2013. Participants were high-risk NH residents with urinary catheters, feeding tubes, or both. INTERVENTIONS: Multimodal, including preemptive barrier precautions, active surveillance for MDROs and infections, and NH staff education. MAIN OUTCOMES AND MEASURES: The primary outcome was the prevalence density rate of MDROs, defined as the total number of MDROs isolated per visit averaged over the duration of a resident's participation. Secondary outcomes included new MDRO acquisitions and new clinically defined device-associated infections. Data were analyzed using a mixed-effects multilevel Poisson regression model (primary outcome) and a Cox proportional hazards model (secondary outcome), adjusting for facility-level clustering and resident-level variables. RESULTS: In total, 418 NH residents with indwelling devices were enrolled, with 34,174 device-days and 6557 anatomic sites sampled. Intervention NHs had a decrease in the overall MDRO prevalence density (rate ratio, 0.77; 95% CI, 0.62-0.94). The rate of new methicillin-resistant Staphylococcus aureus acquisitions was lower in the intervention group than in the control group (rate ratio, 0.78; 95% CI, 0.64-0.96). Hazard ratios for the first and all (including recurrent) clinically defined catheter-associated urinary tract infections were 0.54 (95% CI, 0.30-0.97) and 0.69 (95% CI, 0.49-0.99), respectively, in the intervention group and the control group. There were no reductions in new vancomycin-resistant enterococci or resistant gram-negative bacilli acquisitions or in new feeding tube-associated pneumonias or skin and soft-tissue infections. CONCLUSIONS AND RELEVANCE: Our multimodal TIP intervention reduced the overall MDRO prevalence density, new methicillin-resistant S aureus acquisitions, and clinically defined catheter-associated urinary tract infection rates in high-risk NH residents with indwelling devices. Further studies are needed to evaluate the cost-effectiveness of this approach as well as its effects on the reduction of MDRO transmission to other residents, on the environment, and on referring hospitals. TRIAL REGISTRATION: clinicaltrials.gov Identifier: NCT01062841.
Authors: Courtney Reynolds; Victor Quan; Diane Kim; Ellena Peterson; Julie Dunn; Matthew Whealon; Leah Terpstra; Hildy Meyers; Michele Cheung; Bruce Lee; Susan S Huang Journal: Infect Control Hosp Epidemiol Date: 2010-11-18 Impact factor: 3.254
Authors: Joan M Teno; Zhanlian Feng; Susan L Mitchell; Sylvia Kuo; Orna Intrator; Vincent Mor Journal: J Am Geriatr Soc Date: 2008-03-05 Impact factor: 5.562
Authors: Adam L Cohen; David Calfee; Scott K Fridkin; Susan S Huang; John A Jernigan; Ebbing Lautenbach; Shannon Oriola; Keith M Ramsey; Cassandra D Salgado; Robert A Weinstein Journal: Infect Control Hosp Epidemiol Date: 2008-10 Impact factor: 3.254
Authors: Rajiv Jain; Stephen M Kralovic; Martin E Evans; Meredith Ambrose; Loretta A Simbartl; D Scott Obrosky; Marta L Render; Ron W Freyberg; John A Jernigan; Robert R Muder; LaToya J Miller; Gary A Roselle Journal: N Engl J Med Date: 2011-04-14 Impact factor: 91.245
Authors: Yuchi Young; Nancy R Barhydt; Suzanne Broderick; Anna D Colello; Edward L Hannan Journal: J Am Geriatr Soc Date: 2010-04-06 Impact factor: 5.562
Authors: Philip W Smith; Gail Bennett; Suzanne Bradley; Paul Drinka; Ebbing Lautenbach; James Marx; Lona Mody; Lindsay Nicolle; Kurt Stevenson Journal: Infect Control Hosp Epidemiol Date: 2008-09 Impact factor: 3.254
Authors: Daniel J Morgan; Hannah R Day; Jon P Furuno; Atlisa Young; J Kristie Johnson; Douglas D Bradham; Eli N Perencevich Journal: Infect Control Hosp Epidemiol Date: 2010-10-28 Impact factor: 3.254
Authors: Kevin Heinze; Mohammed Kabeto; Emily Toth Martin; Marco Cassone; Liam Hicks; Lona Mody Journal: Am J Infect Control Date: 2018-11-28 Impact factor: 2.918
Authors: Lona Mody; M Todd Greene; Jennifer Meddings; Sarah L Krein; Sara E McNamara; Barbara W Trautner; David Ratz; Nimalie D Stone; Lillian Min; Steven J Schweon; Andrew J Rolle; Russell N Olmsted; Dale R Burwen; James Battles; Barbara Edson; Sanjay Saint Journal: JAMA Intern Med Date: 2017-08-01 Impact factor: 21.873
Authors: Lona Mody; Jennifer Meddings; Barbara S Edson; Sara E McNamara; Barbara W Trautner; Nimalie D Stone; Sarah L Krein; Sanjay Saint Journal: Clin Infect Dis Date: 2015-03-26 Impact factor: 9.079
Authors: Arti Hurria; Kevin P High; Lona Mody; Frances McFarland Horne; Marcus Escobedo; Jeffrey Halter; William Hazzard; Kenneth Schmader; Heidi Klepin; Sei Lee; Una E Makris; Michael W Rich; Stephanie Rogers; Jocelyn Wiggins; Rachael Watman; Jennifer Choi; Nancy Lundebjerg; Susan Zieman Journal: J Am Geriatr Soc Date: 2017-01-16 Impact factor: 5.562
Authors: Marco Cassone; Julia Mantey; Mary Beth Perri; Kristen Gibson; Bonnie Lansing; Sara McNamara; Payal K Patel; Vincent C C Cheng; Maroya S Walters; Nimalie D Stone; Marcus J Zervos; Lona Mody Journal: Clin Infect Dis Date: 2018-08-31 Impact factor: 9.079
Authors: Barbara W Trautner; M Todd Greene; Sarah L Krein; Heidi L Wald; Sanjay Saint; Andrew J Rolle; Sara McNamara; Barbara S Edson; Lona Mody Journal: Infect Control Hosp Epidemiol Date: 2016-10-04 Impact factor: 3.254